Fishawack Communications
Medical communications agency
Contributing Sustainable Development Goals
Background
We became investment partners wish Fishawack Communications in March 2013 to support the founders’ ambitious international buy and build growth plan. They are a specialist medical communications agency providing a range of outsourced professional services to assist large global pharmaceutical companies in educating the medical sector on pharmaceutical products. The business was founded in 2001 by CEO, Oliver Dennis and CFO, Dominic Miller.
During the period of our investment the revenues and EBITDA doubled as the group became a full-service medical communications agency working on global accounts for large pharmaceutical clients such as GSK, Sanofi and Novartis across UK, Switzerland and USA.
In January 2017 we completed the successful sale of Fishawack to a financial buyer.
Accelerating Growth
Commercial
-
M&A - Our funding and hands on M&A support enabled the execution of three strategic bolt-on acquisitions: Archimed, JK Associates Inc and Facilitate Limited
People & Organisation
Leadership
-
Senior Team - Significant organisational structure changes and board level recruitment: Chairman, CFO, Head of USA, was undertaken to support the increased scale of the group
Platform for Success
Finance and Operations
-
Finance Function - Finance function evolution and improved KPI’s for reporting and decision making
-
Operating Systems - Evolution of management reporting and KPI tracking to drive improved margins, better quality of earnings and revenue visibility
Delivering the Best Outcome
-
High-Quality Delivery - We funded the entire investment , providing the debt and equity on the deal and committed funding for acquisitions
- We led a senior debt refinancing process to provide further firepower for acquisitions
-
Maximising Value Through Process - Strong organic growth with earnings more than doubling during investment